Patent US4191743A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4191743A Expired / Lapsed US ⏱️ 0.0 years remaining

Antibacterial wound dressing

Assignee: Merck Patent GmbH
•
Filing: 1977-11-02
•
Granted: 1980-03-04
•
Expires: 1997-11-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Antibiotics can be effectively administered to wounds over long time periods by a wound dressing which comprises at least two layers of synthetic resin arranged one above the other and an intermediate layer composed of a synthetic resin granulate (particle size: 0.5-3mm) having an antibiotic incorporated therein.

Inventors

  • 👤 Klaus Klemm
  • 👤 Helmut Wahlig

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:46
CPC Classifications
A; A61; A61L; A61L15/00; A61L15/16; A61L15/42; A61L15/46; A61L2300/00; A61L2300/40; A61L2300/404; A61L2300/406

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 80 words
A sterile wound dressing comprising two layers of synthetic resin arranged one above the other and an intermediate layer of an antibiotic within hardened, formed spheroids of a synthetic resin granulate, having a particle size of 0.5-3 mm., wherein the synthetic resin granulate comprises a copolymer of methacrylic acid methyl ester and methyl acrylate, and the antibiotic is selected from gentamycin, neomycin, kanamycin, tobramycin or other aminoglycoside antibiotics, erythromycin, lincomycin, clindamycin, novibiocin, vancomycin, fusidic acid, rifamycin, polymyxins, penicillins, and caphalosporins.
Claim 2
Dependent Claim 80 words
A sterile wound dressing comprising two layers of synthetic resin arranged one above the other and an intermediate layer of an antibiotic within hardened, formed spheroids of a synthetic resin granulate, having a particle size of 0.5-3 mm., wherein the synthetic resin granulate comprises a copolymer of methacrylic acid methyl ester and methyl acrylate, and the antibiotic is selected from gentamycin, neomycin, kanamycin, tobramycin or other aminoglycoside antibiotics, erythromycin, lincomycin, clindamycin, novibiocin, vancomycin, fusidic acid, rifamycin, polymyxins, penicillins, and caphalosporins.
Claim 3
Dependent Claim 19 words
The wound dressing of claim 1, wherein the synthetic resin granulate has a particle size of about 1 mm.
Claim 4
Dependent Claim 25 words
A wound dressing of claim 1, wherein the synthetic resin granulate is arranged as a closely packed layer between the layers of synthetic resin material.
Claim 5
Dependent Claim 11 words
The wound dressing of claim 1, wherein the antibiotic is gentamycin.
Claim 6
Dependent Claim 22 words
A method of administering an antibiotic to a wound which comprises dressing the wound with the sterile wound dressing of claim 1.

References Cited (Backward Citations)

US2430740A Cited
US3055297A Cited
US3551556A Cited
US3660563A Cited
US3881026A Cited
US3598122A Cited
US3598122B1 Cited
US3857932A Cited
US3641237A Cited
US3648692A Cited
US3882858A Cited
US4059684A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-03-04 1983-09-03 1984-03-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-03-04 1987-09-03 1988-03-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-03-04 1991-09-03 1992-03-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag